In clinical practice, the most common tumor markers utilized in breast cancer diagnosis and prognosis are CA15‐3 and CEA (Martelotto et al., 2014; Molina et al., 2010; Park et al., 2008). This evidence concerns the gene CEACAM5 and breast carcinoma.